Substance Use Disorder Treatment Market | Global Analysis Report 2022-2032
An increasing number of treatment centers, with mergers
with private recovery institutions to aid in the extension of treatment access
to a wide range of people is likely to accelerate market growth. However, the
high cost of substance use disorder treatment therapy is likely to hamper the
market size in developing economies due to patients having a limited income.
On the contrary, surging initiatives and funding by the
government for the awareness and treatment of chronic-ill effects of substance
abuse is likely to expand the substance use disorder treatment market size
during the forecast period.
The substance use disorder treatment market is likely to
expand due to the growth in the use of tobacco in developing and underdeveloped
countries, especially in the Pacific and East Asian countries. Moreover, the
implementation of strategic initiatives amongst several market players is
expected to drive market growth further.
Favourable reimbursement policies and treatment
advancements due to the psychological effects of substance abuse are
anticipated to surge the market share. Furthermore, government investments in
technology and telecommunication to improve the healthcare infrastructure is
likely to contribute to market growth.
Prevention programs and increasing drug awareness crusades
to provide information on the risks of mixing drugs and the stigma around drug
use to support treatment and recovery are expected to propel the market share.
These include a higher treatment-seeking rate, increased government
intervention, encouragement to curb substance abuse, and increased patient
awareness.
Technological Advancements Bring the Treatment
to New Horizons
Technological advancements surging the production of
digital devices is likely to aid in substance use disorder treatment. Hence,
the increasing penetration of digitization is positively impacting the market
share.
The substance use disorder treatment market size is
expected to increase using government support. In addition, ‘The
Confidentiality of Substance Use Disorder Patient Records Regulation’ assures
confidentiality for individuals being treated for substance use disorder
treatment, which is expected to boost the market growth.
Increasing awareness about the dangerous aftermath of
alcohol abuse and the rise in the number of rehabilitation facilities are
forecasted to propel the market. Moreover, the wide variety of options for
alcohol addiction treatment, such as counselling, group therapy, and
medication, are anticipated to bolster the substance use disorder treatment
market.
Drug compounding catering to the need of every individual
patient significantly boosts the global market growth. Furthermore, the demand
for substance use disorder treatment is likely to rise owing to the presence of
experienced psychologists to conduct therapy and skilled professionals capable
of executing drug compounding.
The awareness about the impact of substance use disorder
through various campaigns by non-profit organizations and governments through
advertisements on television, newspapers, magazines, etc., has witnessed
remarkable growth. This is estimated to expand the market size.
Reluctance to Opt for Treatment to be a Key
Market Impeder
Poor treatment compliance in some countries and the
reluctance of individuals to access treatment modalities are likely to hinder
the market growth. Likewise, the market is expected to impede due to the
discontinuation of behavioural therapies leading to relapse and patients opting
for outpatient care.
Extending periods of clinical trials, as well as incomplete
health treatment programs, are expected to obstruct the market share.
Similarly, inadequate services for treating substance abuse present a
significant challenge for the market.
What are the Revenue Opportunities for the
Substance Use Disorder Treatment Market?
The high prevalence of comorbid illnesses is accountable to
wrong prescription drugs. Therefore, the rising consumption of non-medical
prescription drugs and increasing overdose deaths are expected to propel market
growth in the coming years.
The high proportion of e-cigarette users in urban areas
provides a lucrative opportunity for the substance use disorder treatment market.
This is owing to research on E-cigarettes that estimated several major health
issues linked with tobacco use.
How is the Performance of the North America
Substance Use Disorder Treatment Market?
North America is the most dominating substance use disorder
treatment market, with a significant share of 46.7% in 2022. This is owing to
the surge in government initiatives aimed at reducing substance abuse, as well
as the rise in tobacco use.
The dependence of about 20 Mn people on both alcohol and
illicit drugs in the U.S is likely to drive the market growth. Moreover, mental
illness as a consequence of drug abuse is further expected to expand the market
size in this region.
The consolidation of smaller rehabilitation centres by
major rehab centres providing uniformity in treatment patterns bolsters the
market share in this region. Additionally, the expansion of rehab centres and
their increasing capacity is anticipated to drive the demand for substance use
disorder treatment.
How will the Europe Substance Use Disorder
Treatment Market Grow?
With a revenue share of 37.4% in 2022, Europe is another
dominating substance use disorder market. This is attributed to the massive
rise in cases of substance abuse and a profusion of government initiatives.
The rising prevalence of alcohol abuse amongst the majority
of the population, leading to disturbing behavioural patterns, is expected to
drive the market. Moreover, increasing death rates due to drug overdose or
alcohol intoxication is likely to further contribute to market growth.
What is the Growth Outlook for the Asia Pacific
Substance Use Disorder Treatment Market?
The Asia Pacific is a growing substance use disorder market
attributed to the rising healthcare expenditure and awareness about the
aftermath of substance abuse.
Nicotine addiction is the highest substance use disorder in
this region. Thus, it is likely to significantly contribute to the global
market’s growth.
What is the Competitive Landscape of the
Substance Use Disorder Treatment Market?
Key market participants are continually educating
themselves to develop a deeper understanding of psychological issues in people,
emerging from prolonged substance abuse. Through mergers and acquisitions,
along with increasing awareness through campaigns, they are coming up with
enhanced treatment options.
Key companies profiled
Teva Pharmaceutical Industries Ltd., Reckitt Benckiser
Pharmaceuticals Inc., GlaxoSmithKline plc, Alkermes plc., Pfizer Inc., Cipla
Limited, Intas Biopharmaceuticals, Alkermes, Allergan plc, Indivior plc,
Noramco, Mallinckrodt plc, BioCorRx Inc., Glenmark Pharmaceuticals Ltd., Dr.
Reddy’s Laboratories, Purdue Pharma L.P., Orexo AB, etc.
Key Segments Profiled in the Substance Use
Disorder Treatment Market Survey
By Type:
- Alcohol
Abuse Treatment
- Nicotine
Abuse Treatment
- Drug
Abuse Treatment
By Treatment:
- Detoxification
- Counselling
& Behavioural Therapy
- Medication
- Support
Group
By Region:
- North
America
- Latin
America
- Asia
Pacific
- MEA
- Europe
Read More @ https://www.futuremarketinsights.com/reports/substance-use-disorder-treatment-market
Comments
Post a Comment